Findings

What do systematic reviews say?

3 questions · 3 findings · 3 reviews · Neuromuscular

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 1 · 33.3%Low 2 · 66.7%Moderate 0 · 0%High 0 · 0%

Idebenone vs placebo

Non‐serious adverse events · people with Duchenne muscular dystrophy and progressive respiratory decline

Idebenone showed no clear difference in non‐serious adverse events compared with placebo (low certainty).

1 finding from 1 review

Antioxidants to prevent respiratory decline in people with Duchenne muscular dystrophy and progressive respiratory… 2021 · Cochrane Headline outcomes only
RR 1 [0.88, 1.13]
1 study · 66 participants
Low

Bioengineered devices vs standard techniques

Adverse events assessed as: adverse events (serious and non‐serious) · people undergoing peripheral nerve repair of the upper limb

It is very uncertain whether bioengineered devices changes adverse events assessed as: adverse events (serious and non‐serious) compared with standard techniques (very low certainty).

1 finding from 1 review

Bioengineered nerve conduits and wraps for peripheral nerve repair of the upper limb 2022 · Cochrane Headline outcomes only
RR 7.15 [1.74, 29.42]
5 studies · 213 participants
Very low

Intervention not reported

Non‐serious adverse eventsClinical manifestation and laboratory examination · people with acute herpes zoster (within 7 days of onset of rash)

The intervention showed no clear difference in non‐serious adverse eventsClinical manifestation and laboratory… (low certainty).

1 finding from 1 review

Corticosteroids for preventing postherpetic neuralgia 2023 · Cochrane Headline outcomes only
RR 1.3 [0.9, 1.87]
5 studies · 755 participants
Low